Lannett Company Inc. recalls

3 recalls.

• Dextroamphetamine Saccharate recall (Lannett Company Inc.)
  DrugClass IIReported July 8, 2026 · Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
• Niacin Extended-release Tablets recall (Lannett Company Inc.)
  DrugClass IIReported June 10, 2026 · Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
• Primidone Tablets USP recall (Lannett Company Inc.)
  DrugClass IIIReported May 27, 2026 · Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.